RNU7-24P

Across TCGA pan-cancer cohorts, RNU7-24P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU7-24P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU7-24P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-24P expression acts as an unfavorable survival marker.

BRCA, STAD, and KIRC are the cancer types where RNU7-24P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.138	0.580	<.001	72	view →
STAD	DFS	Tertile	All	0.221	0.728	<.001	54	view →
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	54	view →
THCA	DFS	Tertile	All	0.062	0.811	<.001	36	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU7-24P–BRCA (OS)

Open the BRCA breakdown →